93955-15-8,
6-chloro-4-(2-chlorophenyl)quinazoline-2-carbaldehyde,
Lorazepam Related Compound C,
UNII-8RF5NW66M0,
6-chloro-4-(2-chlorophenyl)-2-Quinazolinecarboxaldehyde,
8RF5NW66M0,
6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde,
2-Quinazolinecarboxaldehyde, 6-chloro-4-(2-chlorophenyl)-,
Lorazepam impurity E [EP],
Lorazepam related compound C [USP],
Lorazepam related compound C RS [USP],
AC1LDFAE,
AC1Q3JZ6,
SCHEMBL6502520,
CTK5H4167,
DTXSID40239938,
VUUITUUENPOMIU-UHFFFAOYSA-N,
ZINC163592,
ZX-AT018025,
MFCD01570906,
OR27735,
SC-65956,
DB-079735,
FT-0664616,
6-Chloro-4-(2-chlorophenyl)quinazoline-2-carbaldeh,
4-(2-Chlorophenyl)-6-chloroquinazoline-2-carbaldehyde,
6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarbaldehyde #,
6-Chloro-4-(2-chlorophenyl)-quinazoline-2-carbaldehyde,
6-chloro-4-(o-chlorophenyl)-quinazoline-2-carboxaldehyde,
Quinazoline-2-carboxaldehyde, 6-chloro-4-(2-chlorophenyl)-,
Lorazepam Related Compound C, United States Pharmacopeia (USP) Reference Standard,
CID617488,
ZINC00163592,
CS-T-11370,
6-CHLORO-4- QUINAZOLINE-2-CARBALDEHYDE,